atorvastatin has been researched along with Psoriasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Block, R; Brenna, JT; Drenkova, K; Garshick, MS; James, G; Tawil, M | 1 |
| Attwa, EM; Benjuma, HH; Ibrahim, AM | 1 |
| DeMicco, DA; Fayyad, R; Laskey, R; Ports, WC; Wolk, R | 1 |
| Kanwar, AJ; Kaul, D; Parsad, D; Soodgupta, D | 1 |
| Jaji, MS; Krishnan, UM; Kulkarni, NM; Mookkan, J; Muley, MM; Narayanan, S; Raghul, J; Rajesh, NB; Reddy, NK; Vijaykanth, G; Vishwakarma, SL | 1 |
| Perlamutrov, IuN; Shkol'nik, EL; Shkol'nik, MN; Vasiuk, IuA | 1 |
| Ehsani, AH; Faghihi, T; Mehrabian, Z; Radfar, M; Rezaei Hemami, M | 1 |
4 trial(s) available for atorvastatin and Psoriasis
| Article | Year |
|---|---|
Statin therapy upregulates arachidonic acid status via enhanced endogenous synthesis in patients with plaque psoriasis.
Topics: Arachidonic Acid; Atorvastatin; Delta-5 Fatty Acid Desaturase; Fatty Acid Desaturases; Fatty Acids; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linoleic Acid; Male; Psoriasis | 2022 |
Effectiveness of Lipid-Lowering Statin Therapy in Patients With and Without Psoriasis.
Topics: Aged; Atorvastatin; Cardiovascular Diseases; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Male; Middle Aged; Psoriasis | 2017 |
[Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension].
Topics: Atorvastatin; Blood Pressure; Dose-Response Relationship, Drug; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Male; Middle Aged; Psoriasis; Pyrroles; Quality of Life; Severity of Illness Index; Skin; Treatment Outcome | 2010 |
Atorvastatin for the treatment of plaque-type psoriasis.
Topics: Administration, Oral; Adolescent; Adult; Atorvastatin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Male; Middle Aged; Prospective Studies; Psoriasis; Pyrroles; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
3 other study(ies) available for atorvastatin and Psoriasis
| Article | Year |
|---|---|
The exacerbating effect of atorvastatin on psoriasis.
Topics: Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Psoriasis | 2022 |
Modulation of LXR-α and the effector genes by Ascorbic acid and Statins in psoriatic keratinocytes.
Topics: Adolescent; Adult; Antioxidants; Ascorbic Acid; Atorvastatin; Female; Gene Expression Regulation; Heptanoic Acids; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Liver X Receptors; Male; Orphan Nuclear Receptors; Psoriasis; Pyrroles | 2014 |
Topical atorvastatin ameliorates 12-O-tetradecanoylphorbol-13-acetate induced skin inflammation by reducing cutaneous cytokine levels and NF-κB activation.
Topics: Animals; Atorvastatin; Cell Proliferation; Cytokines; Dermatitis; Dose-Response Relationship, Drug; Ear, External; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Keratinocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Psoriasis; Skin; Tetradecanoylphorbol Acetate | 2015 |